• 12/01/2020

    The story of Abdurahim

    Four-year-old Abdurahim from Kyrgyzstan is so small he looks half that age. He had spinal and intra-thoracic lymph node tuberculosis…

    Lees meer
  • 12/12/2019

    Start of a new era in fight against drug resistant TB

    WHO released a rapid communication on the treatment of drug resistant (DR) and extensively drug resistant (XDR) tuberculosis (TB). This…

    Lees meer
  • 20/11/2019

    7th European Advanced Course in Clinical Tuberculosis

    The 7th European Advanced Course in Clinical Tuberculosis (TB) offered an informative and interactive program with national and international speakers…

    Lees meer
  • 31/10/2019

    3HP regimen soon to be accessible in Malawi

    KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the…

    Lees meer
  • 31/10/2019

    Important price reduction improves access to TB prevention

    KNCV Tuberculosis Foundation welcomes the announcement of a substantial reduction in the price of an anti-tuberculosis medicine through the support…

    Lees meer
  • 25/09/2019

    Innovative TB treatment support project kicks off in the Philippines

    ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment…

    Lees meer
  • 01/09/2019

    Antacid helps tuberculosis bacteria to survive

    In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection…

    Lees meer
  • Current recommended treatment regimen for highly drug-resistant TB (left) versus the BPaL regimen (right).

    14/08/2019

    FDA approval of BPaL regimen an important breakthrough in TB control

    The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB)…

    Lees meer
  • 23/07/2019

    ASCENT: Empowering patients through digital technology

    GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands…

    Lees meer
  • 20/06/2019

    Call to Action for awareness on AMR

    KNCV Tuberculosis Foundation is one of the civil society organizations that signs the Call to Action for awareness on antimicrobial…

    Lees meer
  • 28/05/2019

    Wolfheze Workshops 2019: inspiring knowledge exchange & concrete steps forward

    KNCV Tuberculosis Foundations can look back at an inspiring edition of the Wolfheze Workshops 2019 (15-17…

    Lees meer
  • 15/05/2019

    Unique gathering of TB and HIV experts in Scheveningen

    Biennial Wolfheze Workshops focuses on alarming tandem of infectious diseases THE HAGUE, 15 May 2019 International experts in the field…

    Lees meer
  • 12/04/2019

    Dutch civil society calls upon increase of Dutch commitment to the Global Fund

    The Hague – This week, KNCV Tuberculosis Foundation, in cooperation with Aidsfonds and nine other Dutch civil society organisations* called…

    Lees meer
  • 24/03/2019

    IT’S TIME … for new TB drugs and treatment regimens for all

    THE HAGUE – Today, on World TB Day, the international TB community raises awareness about the deadliest infectious disease in…

    Lees meer
  • 19/03/2019

    TB remains major public health challenge in European region

    The latest WHO/ECDC report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.